Search Results 3751-3760 of 33427 for oral

1. Development of Biomarkers Differentiating Post-infectious From Neurodegenerative Smell Loss - Mayo Clinic

   Patients on chronic oral steroid therapy, oral corticosteroids in the past 4 weeks before enrollment; or intramuscular corticosteroids in the past 12 weeks ...

2. Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

   Chronic use of oral anticoagulants (i.e., coumadin or novel oral anticoagulant [NOAC]). Chronic use of any prohibited medication. NOTE: Additional inclusion ...

3. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

4. Controlled Trial Evaluating Avacopan in C3 Glomerulopathy - Mayo Clinic

   ... [oral, intravaginal, or transdermal], or progestogen-only hormonal contraception (oral, injectable, or implantable), intra-uterine device, intra-uterine ...

5. Dermatitis - Doctors and departments - Mayo Clinic

   ... Oral lichen planus, Nonmelanoma skin cancer, Tuberous sclerosis, Klippel-Trenaunay syndrome, Melasma, Alopecia areata, Diffuse capillary malformation with ...

6. A Study to Evaluate Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery - Mayo Clinic

   Diagnosis of PBH by a physician, requiring intervention such as intake of oral carbohydrates. This diagnosis includes documentation of endogenous ...

7. Sarcoma - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Microvascular surgery, Facial reconstruction, Skull base surgery, Glossectomy, Tracheostomy, Skin cancer reconstruction, Submandibular gland ...

8. Assess Glycemic Improvements in People with Type 2 Diabetes Using a Novel Hybrid Closed Loop Insulin Pump - Mayo Clinic

   ... (oral, intravaginal, transdermal). Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable,implantable). Placement ...

9. Trevogrumab or Trevogrumab with Garetosmab when taken with Semaglutide in patients with obesity. - Mayo Clinic

   ... (oral, injectable, implantable) associated with inhibition of ovulation initiated 2 or more menstrual cycles prior to screening;; intrauterine device ...

10. Parkinson's Disease Clinical Trials - Mayo Clinic Research

    This is a 52-week open-label study to evaluate the safety and tolerability of ADS-5102 oral capsules, an extended release formulation of amantadine, in ...